Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial Of Novel PI3K Delta Inhibitor, CAL-101
http://www.medicalnewstoday.com/articles/114896.php
Calistoga Pharmaceuticals, Inc., a company dedicated to developing innovative medicines for the treatment of cancer and inflammatory diseases, announced the initiation of a Phase 1 clinical trial of its lead compound, CAL-101, a small molecule phosphoinositide-3 kinase (PI3K) delta inhibitor, in patients with hematologic cancer.
Elusive Target In Cancer Cells Targeted By Magnolia Compound
http://www.medicalnewstoday.com/articles/114841.php
A natural compound from magnolia cones blocks a pathway for cancer growth that was previously considered "undruggable," researchers have found.A laboratory led by Jack Arbiser, MD, PhD, at Emory University School of Medicine, has been studying the compound honokiol, found in Japanese and Chinese herbal medicines, since discovering its ability to inhibit tumor growth in mice in 2003.
Cancer Drug Reformulation Featured In Prestigious Journal
http://www.medicalnewstoday.com/articles/114838.php
Dr. Yuri Lvov, a professor of chemistry and T. Pipes endowed chair in micro and nanosystems at Louisiana Tech University, and Anshul Agarwal, a Louisiana Tech doctoral candidate in biomedical engineering feature their cancer drug reformulation work in the most recent issue of <i>Pharma Focus Asia</i>, one of the largest and most respected pharmaceutical science journals in the world.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Merck, FDA Update Potential Adverse Reactions To HPV Vaccine Gardasil, Washington Times Reports
http://www.medicalnewstoday.com/articles/114810.php
<BR />The <A href="http://washingtontimes.com/news/2008/jul/10/merck-fda-expand-gardasil-warnings/" target=_new><CITE>Washington Times</CITE></A><CITE> </CITE>on Thursday reported that Merck and FDA last month added potential adverse reactions to Merck's human papillomavirus vaccine Gardasil to the package insert and information sheet given to patients.
----------------------------------------------
** COLORECTAL CANCER News **
Exact Sciences Provides Regulatory Update For Its Version 2 Stool-Based DNA Technology For Colorectal Cancer Screening
http://www.medicalnewstoday.com/articles/114897.php
EXACT Sciences Corporation (NASDAQ: EXAS) announced that it has confirmed with the U.S. Food and Drug Administration (FDA) the clinical performance characteristics and the minimum number of average-risk cancer samples that will be required for validation of its Version 2 stool-based DNA technology for colorectal cancer screening.
ACR's Guidelines For CT Colonography Interpretation Examined In Study At Digestive Disease Week
http://www.medicalnewstoday.com/articles/114848.php
A study presented at Digestive Disease Week® 2008 examined the American College of Radiology's (ACR) CT colonography guidelines recommending that polyps ≤ 5mm in size not be reported on CT colonography by applying them to an endoscopic database that collected information about polyps that had been removed and processed.
Colorectal Cancer Screening Rates Still Too Low
http://www.medicalnewstoday.com/articles/114537.php
Although colorectal cancer screening tests are proven to reduce colorectal cancer mortality, only about half of U.S. men and women 50 and older receive the recommended tests, according to a report in the July 2008 issue of <a href="http://cebp.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Hutchinson Cancer Research Center Researcher Develops Method For Early Detection Of Leukemia Relapse
http://www.medicalnewstoday.com/articles/114892.php
Researchers at the Fred Hutchinson Cancer Research Center have developed a method that allows for the early detection of a common mechanism of resistance on drug treatment for chronic myeloid leukemia.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Theragenics Corporation(R) Engages Men In A National Debate On Prostate Cancer
http://www.medicalnewstoday.com/articles/114891.php
Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment